Show
Sort by
-
Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial
-
- Journal Article
- A1
- open access
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer
-
Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
-
- Journal Article
- A1
- open access
Management of patients with advanced prostate cancer : report of the Advanced Prostate Cancer Consensus Conference 2019
-
The case against the European Medicines Agency's change to the label for radium-223 for the treatment of metastatic castration-resistant prostate cancer
-
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial
-
- Journal Article
- A1
- open access
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
-
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
-
Consensus on molecular imaging and theranostics in prostate cancer
-
- Journal Article
- A1
- open access
Management of patients with advanced prostate cancer : the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017